GSA Capital Partners’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,739	Closed	-$798K	–	1922
2025 Q3	$798K	Buy	+1,739	New	+$649K	0.07%	550
2023 Q2	–	Sell	-3,240	Closed	-$785K	–	1771
2023 Q1	$785K	Buy	+3,240	New	+$883K	0.08%	451
2022 Q1	–	Sell	-4,780	Closed	-$405K	–	1652
2021 Q4	$405K	Sell	4,780 -4,376	-48%	-$360K	0.05%	737
2021 Q3	$731K	Buy	9,156 +4,153	+83%	+$359K	0.07%	468
2021 Q2	$487K	Buy	+5,003	New	+$592K	0.05%	645
2021 Q1	–	Sell	-3,334	Closed	-$371K	–	1324
2020 Q4	$371K	Buy	+3,334	New	+$408K	0.06%	628
2020 Q1	–	Sell	-12,241	Closed	-$1.11M	–	1350
2019 Q4	$1.11M	Buy	12,241 +8,564	+233%	+$831K	0.13%	161
2019 Q3	$317K	Buy	+3,677	New	+$345K	0.04%	854
2018 Q3	–	Sell	-1,702	Closed	-$476K	–	1783
2018 Q2	$476K	Buy	+1,702	New	+$299K	0.02%	1183
2015 Q2	–	Sell	-894	Closed	-$61K	–	2090
2015 Q1	$61K	Buy	+894	New	+$76.7K	﹤0.01%	2047